Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Change in Account Payables: 2011-2014

Historic Change in Account Payables for Capricor Therapeutics (CAPR) over the last 3 years, with Jun 2014 value amounting to -$51,818.

  • Capricor Therapeutics' Change in Account Payables fell 113.03% to -$51,818 in Q2 2014 from the same period last year, while for Jun 2014 it was $419,806, marking a year-over-year decrease of 47.56%. This contributed to the annual value of $97,512 for FY2013, which is N/A change from last year.
  • Capricor Therapeutics' Change in Account Payables amounted to -$51,818 in Q2 2014, which was down 620.10% from $9,963 recorded in Q1 2014.
  • Over the past 5 years, Capricor Therapeutics' Change in Account Payables peaked at $504,333 during Q3 2011, and registered a low of -$110,683 during Q1 2012.
  • Moreover, its 3-year median value for Change in Account Payables was $122,068 (2012), whereas its average is $123,135.
  • Data for Capricor Therapeutics' Change in Account Payables shows a peak YoY increase of 375.08% (in 2012) and a maximum YoY decrease of 175.56% (in 2012) over the last 5 years.
  • Over the past 4 years, Capricor Therapeutics' Change in Account Payables (Quarterly) stood at -$66,496 in 2011, then surged by 375.08% to $182,916 in 2012, then tumbled by 33.08% to $122,416 in 2013, then crashed by 113.03% to -$51,818 in 2014.
  • Its Change in Account Payables stands at -$51,818 for Q2 2014, versus $9,963 for Q1 2014 and $122,416 for Q4 2013.